Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease

被引:0
作者
Dagmar E. Ehrnhoefer
Dale D. O. Martin
Mandi E. Schmidt
Xiaofan Qiu
Safia Ladha
Nicholas S. Caron
Niels H. Skotte
Yen T. N. Nguyen
Kuljeet Vaid
Amber L. Southwell
Sabine Engemann
Sonia Franciosi
Michael R. Hayden
机构
[1] University of British Columbia,Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, Department of Medical Genetics
[2] Present address: BioMed X Innovation Center,undefined
来源
Acta Neuropathologica Communications | / 6卷
关键词
Huntington disease; Autophagy; Proteolysis; Caspase; Mutant huntingtin lowering;
D O I
暂无
中图分类号
学科分类号
摘要
Huntington disease (HD) is caused by the expression of mutant huntingtin (mHTT) bearing a polyglutamine expansion. In HD, mHTT accumulation is accompanied by a dysfunction in basal autophagy, which manifests as specific defects in cargo loading during selective autophagy. Here we show that the expression of mHTT resistant to proteolysis at the caspase cleavage site D586 (C6R mHTT) increases autophagy, which may be due to its increased binding to the autophagy adapter p62. This is accompanied by faster degradation of C6R mHTT in vitro and a lack of mHTT accumulation the C6R mouse model with age. These findings may explain the previously observed neuroprotective properties of C6R mHTT. As the C6R mutation cannot be easily translated into a therapeutic approach, we show that a scheduled feeding paradigm is sufficient to lower mHTT levels in YAC128 mice expressing cleavable mHTT. This is consistent with a previous model, where the presence of cleavable mHTT impairs basal autophagy, while fasting-induced autophagy remains functional. In HD, mHTT clearance and autophagy may become increasingly impaired as a function of age and disease stage, because of gradually increased activity of mHTT-processing enzymes. Our findings imply that mHTT clearance could be enhanced by a regulated dietary schedule that promotes autophagy.
引用
收藏
相关论文
共 410 条
  • [21] Seibenhener ML(2010)Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo J Neurosci 30 15019-165
  • [22] Peng J(2012)Caspase-6-resistant mutant huntingtin does not rescue the toxic effects of caspase-cleavable mutant huntingtin in vivo J Huntington’s Dis 1 243-158
  • [23] Strom AL(2006)Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin Cell 125 1179-19394
  • [24] Kemppainen R(1996)Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype Hum Mol Genet 5 1875-222
  • [25] Cox N(2011)Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway Nat Med 18 159-527
  • [26] Zhu H(2011)Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets Nat Med 18 153-392
  • [27] Wooten MC(1996)Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme J Biol Chem 271 19385-315
  • [28] Diaz-Meco MT(2016)Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Autophagy 12 1-4651
  • [29] Moscat J(2009)Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates Mol Cell 33 517-3179
  • [30] Bae SH(2010)Clearance of mutant proteins as a therapeutic target in neurodegenerative diseases Arch Neurol 67 388-35